HD-OPM Archive
Topics › Infections & vaccines

Horizon trial tests an EBV vaccine in recently diagnosed multiple sclerosis

Louis Nervegna · Aug 28, 2025 · ♥ 6 reactions · 2 comments · original Facebook post
Infections & vaccines
AI summary & key facts

Louis promotes a clinical trial of an investigational Epstein-Barr virus vaccine for people recently diagnosed with MS, based on Harvard research suggesting EBV is a likely cause of MS. This is off-topic for heart disease.

This clinical trial is very promising, if you know someone who was recently diagnosed with MS.

My friend is working on this research at Harvard. Her group discovered that EBV is likely the root cause of MS in people who are vulnerable. The discovery made huge headlines worldwide a few years ago:

Harvard T.H. Chan School of Public HealthEpstein-Barr virus may be leading cause of multiple sclerosis | Harvard T.H. Chan School of Public HealthMultiple sclerosis is likely caused by infection with the Epstein-Barr virus, according to a new Harvard Chan School study.hsph.harvard.edu

Treating the underlying EBV early enough might lead to a major reversal of the disease. They just don’t know, because it has never been tried before. The discovery is still very new. This trial aims to find out.

#msHD #ebvHD #harvardHD

Research cited

Research has shown Epstein-Barr virus (EBV) as a contributing cause of multiple sclerosis (MS). Those recently diagnosed with MS can learn about the Horizon Trial to see if an investigational vaccine for EBV may stop or slow symptoms from progressing.

← newer: Traditional Mediterranean diet food pyramid from Oldwaysolder: Image post saying most listed sweeteners are metabolically e →